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ABSTRACT Psoriasis is a recurrent chronic inflammatory skin 
disease with various mild to severe clinical manifestations. the 
relationship between severity of the skin lesions and nail involve-
ment has always been underestimated. 
Aim of the study was to evaluate the severity of skin involvement 
in psoriatic patients with and without nail manifestations.
in this analytic cross-sectional study, patients with psoriasis re-
ferred to razi University Hospital of rasht from november 2015 
to March 2016 were enrolled. Demographical features (i.e. age, 
gender) were obtained. Psoriasis severity and nail involvement 
criteria were assessed by Psoriasis Area and Severity index (PASi) 
and nail Psoriasis Severity index (nAPSi), respectively. All the 
gathered data were analyzed by SPSS software.
in this study, 71 psoriatic patients with a mean age of 39.23±17.9 
years (mean ± Standard Deviation; range: 4 to 77 years old) were 
studied. 22 patients (31%) had nail involvements. PASi scores 
were 11.7±5.7 and 5.7±4.5 in the two groups with and without 
nail involvements, respectively (P<0.001). there were no signifi-
cant differences between age, age of onset, and duration of the 
disease between the two groups (P>0.05).the correlation coef-
ficient between PASi and nAPSi was 0.367, which was statistically 
significant (P<0.001).
Based on the findings of our study, nail involvement is an impor-
tant criterion in determining the severity of skin manifestations 
in psoriatic patients. Additionally, a high percentage of such 
patients probably manifest both skin and nail manifestations. 
therefore it is highly recommended to consider nail involvement 
when evaluating psoriasis.
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INTRODUCTION
Psoriasis is considered a chronic, recurrent, inflam-
matory disease with underlying cellular immunity 
mediated etiologies (1-3). the disease is found in 1-
3% of the general population. Common clinical mani-
festations include erythematous dry papules and 
plaques in different sites, covered by silvery scales. 
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the various types of the disease which are mainly 
differentiated based on their clinical manifestations 
are: plaque, guttate, scalp, inverse, nail, pustular, and 
erythrodermic (4-6). the patients often suffer from 
the disease throughout their lives as no definite treat-
ment has yet been introduced (7,8). 
Psoriatic skin lesions might start as a simple red 
small papule, later progressing to the characteristic 
plaques (9-11). the scalp, extensor surfaces on the 
limbs, the periumbilical area, sacrum, and nails are the 
most frequent sites for disease presentations (12,13). 
Psoriasis often develops gradually, and pruritus is 
considered the most bothersome symptom among 
the majority of psoriatic patients (60-90%) (14). Some 
etiological factors including genetics, traumas, infec-
tions, medications, psychological stresses, hormonal 
changes, exposure to sunlight, and metabolic reac-
tions have been proven to either trigger the disease 
or to have significant effects on the severity of skin 
symptoms of psoriasis (15-17).
nail manifestations, on the other hand, occur in 
10-55% of all patients with psoriasis. they are often 
diagnosed by close physical examination, particularly 
in the subjects with severe skin presentations (18-20). 
these include pitting, leukonychia, nail plate crum-
bling, oil drop discoloration, onycholysis, hyperkera-
tosis, and splinter hemorrhages (20-22). Proper thera-
peutic approaches to nail manifestations, sometimes 
even with incomplete treatment, leads to relief from 
the social and personal burdens of such symptoms 
(23).
Based on the literature review, there are contradic-
tory studies in regard to the possible relationship be-
tween the severity of skin lesions and nail manifesta-
tions among patients with psoriasis. Although some 
researchers found no relationship, others found a cor-
relation between these symptoms. Moreover, cutane-
ous psoriasis is more severe in individuals with nail 
involvement (7,10,12,15,18). therefore in the present 
study we aimed to evaluate the severity of skin mani-
festations in psoriatic patients with and without nail 
involvements.
PATIENTS AND METHODS
All patients with clinical signs and symptoms of 
psoriasis vulgaris were enrolled in this prospective 
cross-sectional analytical study. the study protocol 
was approved by the ethical and scientific commit-
tee of Guilan University of Medical Sciences (Derma-
tology research Center). A written informed consent 
was obtained from the subjects, following a thor-
ough explanation of the study and based on the con-
sent forms available at www.gums.ac.ir. Moreover, all 
the data were kept completely confidential by the 
authors and the results were reported as overall sta-
tistics not naming any specific individuals. the study 
was carried out from november 2015 to March 2016.
the only inclusion criterion was the presence of 
clinical symptoms of psoriasis vulgaris, while the ex-
clusion criteria were as follows:
1.  Application of artificial or cosmetic nails in the 
past six months.
2.  Patients who did not agree to participate in the 
study.
3.  Patients who took topical or systemic medications 
for skin or nail lesions in the past three months.
4.  Onycholysis or leukonychia due to nail traumas.
5.  Senile hyperkeratosis in the nail bed confirmed by 
the attending dermatology professor.
6.  Hyperkeratosis in the nail bed and onycholysis or 
both in toenails which revealed positive results in 
potassium hydroxide smear (KOH) and culture for 
dermatophytosis.
these patients were divided into two groups, with 
and without nail involvements. Disease severity was 
evaluated according to the Psoriasis Area and Sever-
Table 1. nail involvement frequencies in patients with psoriasis
involved limb Count Percent (in all the psoriatic 
patients, n=71)
Percent (in psoriatic patients with nail 
involvement, n=22)
right hand 18 25.4 81.0
left hand 19 26.8 86.0
right foot 12 16.9 55.0
left foot 13 18.3 59.0
Hand nails 20 28.0 90.0
toenail 15 21.0 68.0
Only hands 6 8.0 27.0
Only feet 2 3.0 9.0
Hands and feet 13 18.0 59.0
nails of all four limbs 8 11.0 36.0
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ity index (PASi) (23), while the nail presentations and 
their severity were recorded based on the nail Psoria-
sis Severity index (nAPSi) criteria.
Frequently used as an endpoint in psoriasis clinical 
trials, PASi is a composite index indicating the sever-
ity of the three main signs of psoriatic plaques (ery-
thema, scaling, and thickness) and is weighted by the 
amount of coverage of these plaques in the four main 
body areas (head, trunk, upper extremities, and lower 
extremities). PASi scores range from 0-72, with higher 
scores indicating greater disease severities (23).
nAPSi has been developed as an objective and 
reproducible tool for estimating nail involvement 
and can therefore be used to determine the efficacy 
of therapeutic interventions. each nail is divided into 
four quadrants, which are evaluated for the presence 
of any manifestations of psoriasis in the nail matrix 
(pitting, leukonychia, nail plate crumbling, and red 
lanula) and nail bed involvement (oil drop, onycholy-
sis, hyperkeratosis, splinter hemorrhages). if any sign 
is present in all four quadrants, the nail is given a 
score of 4; a score of 0 is given if there are no signs of 
involvement in any quadrants. each nail is assigned 
a nail matrix and a nail bed score of 0-4, which are 
combined to yield a total score of 0-8 for each nail. 
All nails may be evaluated, with the total nAPSi score 
being the sum of the scores, up to 80 if only fingers 
(10 nails) are considered or up to 160 if toes are also 
included (20 nails). the nAPSi is reproducible and 
simple to perform (24). 
Subjects were also assessed regarding the age 
at disease onset and duration of psoriasis in the two 
groups. All the data, including demographic features 
(i.e. age, gender), were recorded and then analyzed 
by the SPSS version 19 software. the Kolmogorov-
Smirnov test was applied to evaluate the normality 
of the variables. the results were reported as mean 
and Standard Deviation. the t-test was also used to 
compare the quantitative variables among the two 
Table 3. Comparison between nail manifestations according to Psoriasis Area and Severity index (PASi) and 
nail Psoriasis Severity index (nAPSi)
P Value Subungual 
Hyperkeratosis 
Onycholysis Crumbling Pitting nail manifestation
0.911 29.64±23.41 23.88±21.70 23.50±17.10 25.56±23.72 nAPSi (Mean ± SD*)
0.867 12.65±6.35 11.08±6.23 10.79±3.14 11.37±5.01 PASi (Mean ± SD)
*SD: Standard Deviation
Table 2. Clinical manifestations frequencies in patients with psoriasis
Clinical manifestations Count Percent (in all the psoriatic patients, 
n=71)
Percent (in psoriatic patients 
with nail involvement, n=22)
Pitting 18 32.1 82.0
Crumbling 8 14.2 36.0
leukonychia 1 1.7 5.0
red-spotted lanula 0 0.0 0.0
Onycholysis 16 28.5 73.0
Subungual hyperkeratosis 11 19.6 50.0
Splinter hemorrhage 1 1.7 5.0
Oildrop 1 1.7 5.0
Figure 1. Correlation between Psoriasis Area and Severity 
index (PASi) and nail Psoriasis Severity index (nAPSi) on the 
hands.
Figure 2. Correlation between Psoriasis Area and Severity 
index (PASi) and nail Psoriasis Severity index (nAPSi) on 
feet.
Darjani et al. Acta Dermatovenerol Croat
nail involvement, an indicator of psoriasis skin severity  2018;26(4):307-313
310 ACTA DERMATOVENEROLOGICA CROATICA
groups. Finally, to evaluate the PASi and nAPSi scores 
and correlations, Spearman’s correlation coefficient 
was used.
RESULTS
A total of 71 patients were enrolled in the study 
with a mean age ± Standard Deviation 39.33±17.4 
(ranging from 4 to 77 years). there was a slight male 
predominance in our study (53.5% men and 46.5% 
women). the mean age at disease onset was 29.2 
years (3 to 73 years), while the mean duration of the 
disease was 117.7 months (2 months to 36 years). Pa-
tients with and without nail involvement had a mean 
age of 39.8±13.9 and 38.9±18.9 years, respectively 
(P=0.85). 
23 patients (32.4%) had a positive family history 
of psoriasis. 22 cases (31%) had both nail and skin in-
volvements. Patients with a positive family history of 
psoriasis revealed higher rates of nail involvements 
than others with no family histories (52.2% vs 20.8%, 
P=0.012). Hands were the most common site of af-
fected nails (table 1). 
Pitting (32.1%) and onycholysis (28.5%) were the 
most frequent manifestations of nail involvement in 
our patients, followed by subungual hyperkeratosis 
(19.6%) and nail bed crumbling (14.2%). there were 
also no cases with red spotted lunula (table 2). the 
PASi scores varied from 0.3 to 27.2, with 20 patients ob-
taining scores over 10 and three getting 20. Mean PASi 
scores were 6.7±5.8 and 8.5±6.1 for men and women, 
respectively, with no significant differences (P=0.411). 
there were no significant differences between any 
of the four most frequent nail manifestations of our 
study according to PASi or nAPSi (table 3). 
the main finding of our study was a significant 
correlation between PASi and nAPSi (P<0.05) (Figure 
1, Figure 2, Figure 3). there were no significant rela-
tionships between age, duration of the disease, and 
the age of onset in patients with or without nail in-
volvements (P<0.05) (table 4). 
the mean PASi scores in patients with a positive 
family history of psoriasis were significantly higher 
than those with a negative family history (10±7.2 and 
6.4±4.3 respectively, P=0.01). there was also a signifi-
cant correlation between mean PASi scores and age in 
those with nail involvement (P=0.01, r=0.295). On the 
other hand, no significant correlation was found be-
tween PASi and disease duration (P=0.126, r=0.183).
Correlation coefficients from the Spearman test 
for nAPSi scores of fingernails, toenails, and nails 
on all the hands and feet comparing them with PASi 
scores revealed a significant relationship (correlation 
coefficients: 0.402, 0.299, and 0.367, respectively, 
P<0.05) (Figure 1, Figure 2, Figure 3).
the severity of nail involvement according to nAP-
Si scores in cases with and without family histories of 
psoriasis was significant (33.1±5.9 and 11.6±5.8, re-
spectively, P=0.01). 
We found no correlation between nAPSi and dis-
ease duration (r=0.88, P=0.467) or the age of onset 
(r=0.27, P=0.826).
DISCUSSION
Psoriasis is considered an inflammatory disorder 
with a variety of possible underlying etiologies. the 
disease is found in all nations worldwide and impos-
es significant economic, psychological, and aesthetic 
burdens in different societies. Although various stud-
ies have examined different aspects of the disease, 
much more research is still needed (19,20,25).
Figure 3. Correlation between Psoriasis Area and Severity 
index (PASi) and nail Psoriasis Severity index (nAPSi) on the 
hands and feet.
Table 4. Demographic features and Psoriasis Area and Severity index (PASi) scores in patients with and 
without nail involvement
Variable With nail involvement Without nail involvement t-test Ρ-Value
Age (years, mean ± SD*) 39.8±13.9 38.9±18.9 0.19 0.86
Start age (years, mean ± SD) 29.5±12.7 29.0±17.7 0.10 0.91
Disease duration (months, mean ± SD) 123.5±110.1 115.2±126 0.28 0.78
PASi score (mean ± SD) 11.7±5.7 5.7±4.5 4.75 <0.001
*SD: Standard Deviation
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Among all of the symptoms, skin and nail manifes-
tations were always important as they influence the 
daily functions of individuals. the cosmetic aspects of 
these serious symptoms should also be considered, 
but, conversely, these presentations are often under-
estimated or ignored for some patients (21-23). 
in the present study, we evaluated 71 patients in 
whom 22 cases (31%) manifested nail symptoms. this 
rate was relatively lower than other studies including 
Choi et al. (85.5%), Augustin et al. (40.9%), Brazzelli et 
al. (76.9%), radtke et al. (72.8%), and Hallaji et al. (42%) 
(7,10,15,18,26). We only considered the eight criteria 
of nAPSi as nail involvement, but other studies also 
included other nail manifestations (i.e. paronychia, 
beau lines, color changes of the nails, and longitu-
dinal lines on the nail plates) as nail presentations, 
which can explain the variability of these outcomes 
(10,15,18). Barzegari et al., on the other hand, report-
ed 33% of nail presentation, which is consistent with 
our results (19).
the different prevalence of nail psoriasis in differ-
ent populations reflects the complexity of establish-
ing a precise value of nail psoriasis prevalence in pa-
tients with psoriasis (27).
Pits can be seen in normal individuals and in pa-
tients with chronic eczema, alopecia areata, and li-
chen planus. therefore, looking at the other psoriatic 
nail features would be helpful for the diagnosis of 
psoriatic nail pitting. it has also been suggested that 
pits in patients with nail psoriasis are typically deeper 
than with other dermatological conditions (26). 
De Berker et al. suggested a likely psoriatic cause 
for the presence of more than 20 fingernail pittings. 
More than 60 pits per person are unlikely to be found 
in the absence of psoriasis (28). this was considered as 
the basis for the division of nail pits according to the 
number. in the present study, we considered the to-
tal number of pits in all fingernails to be at least 20 to 
classify it as pitting. Pittings in the group without pso-
riatic nail involvement were less than 20 in number. 
in the present study, PASi scores were higher for 
patients with nail symptoms (11.7 vs 5.7). Hallaji et 
al., Augustin et al., and Brazzelli et al. reported scores 
of 13.16±11.87, 12.7 and 12 for the subject with nail 
presentations, respectively (7,10,18). these studies 
also reported a PASi score of 4.74±4.71, 9.3, and 8.7 
for patients without nail manifestations (7,10,18). 
these results confirm the findings of our study. But 
in radtke et al., Williamson et al., Barzegari et al., and 
Valden et al., PASi scores were not evaluated criteria 
for nail symptoms (4,12,15,19).
there was a significant relationship between PASi 
and nAPSi scores in the present study (P<0.0001), 
while reich et al. found no such relationship among 
their patients (6). Hallaji et al. reported mild to moder-
ate correlations among these two indices (P<0.0001) 
(7), Williamson et al. only considered one section of 
PASi criteria and compared it with nAPSi scores, find-
ing a significant relationships between these two in-
dices (12). Augustin et al. reported that patients with 
nail manifestations had higher PASi scores than those 
without (13.5±10.7 vs. 10±8.6) (10).
We also found no significant relationships be-
tween gender and PASi scores (6.7±5.8 in men and 
8.5±6.1 in women). Brazzelli et al. reported a similar 
non-significant relationship for men (12.9) and wom-
en (9.34) (18), while Augustin et al. found significant 
results among men (11.6±9.7) and women (9.5±8.3), 
(P<0.001) (10).
Unlike other studies, we evaluated the family his-
tory of psoriasis and patients’ age in our subjects, 
which showed a significant relationship with PASi 
scores. this could be due to genetic similarities and 
some interfering environmental factors in our re-
search. regarding the age of subjects, we believe 
that gradual changes in physiological or pathological 
mechanisms related to aging are the possible causes 
of elevated PASi scores in our study. there were also 
no significant relationships between disease duration 
and PASi scores, which has also not been assessed in 
any previous studies.
Augustin et al. found higher rates of nail involve-
ments in patients with a positive family history of 
psoriasis than the ones with no such history (44.3% 
vs 37.3%) (10). Schons et al. also found more often 
reported family history of psoriasis among patients 
with nail psoriasis  compared with those without nail 
involvement (40% vs. 7.4%, P=0.011). this finding was 
echoed in our study (27). 
On physical examination, we found pitting and 
onycholysis was the most common nail presentation. 
Choi et al. also found pitting as the most common clin-
ical feature (55.6%) (26). Brazzelli et al. reported ony-
cholysis as the most common finding in nails (78.8%), 
followed by nail plate crumbling (65.4%), subungual 
hyperkeratosis (53.3%), and pitting, although it was 
mentioned that pitting and onycholysis were the 
most common features of fingernail involvements 
(18). Barzegari et al., on the other hand, reported ony-
cholysis as the most frequent type of nail manifesta-
tion, which is apparently in contrast with the majority 
of the literature, and it is explained in the article that 
the finding is probably due the a small sample size of 
the study (19). Velden et al. only examined the nails 
of the hands and found onycholysis (93.9%), splinter 
hemorrhage (89.9%), and pitting (73.5%) among the 
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patients (4). Williamson et al. confirmed color changes, 
onycholysis, and subungual hyperkeratosis in most of 
the patients, while only 18% of them presented with 
pitting on their nails (12). 
nail manifestations were mostly found in the 
hands of the patients with psoriasis in our study, 
which is similar to studies by Augustin et al. and Braz-
zelli et al. (18).
the mean age of subjects in the present study 
was 39.33 years old (ys/o), while this demographic 
parameter was reported in other studies as follows: 
Velden et al. 48 ys/o, Brazzelli et al. 52.53 ys/o; 53.71 
ys/o in men and 49.8 ys/o in women (4,18), Augustin 
et al. 51.1±18.8 ys/o; 50.6 ys/o in men and 51.8 ys/o in 
women (10). these findings reveal older ages of pa-
tients in previous studies compared with ours. How-
ever, this finding could be due to the small samples 
size in our study. lager studies are needed to confirm 
this finding in our region.
in our study, the age of disease onset was 29.2 
ys/o, while it was 29 ys/o in Velden et al., 37.3±17.3 
ys/o in Brazzelli et al., and 24 ys/o in Barzegari et al 
(18,19).
Finally, we found non-significant differences re-
garding age, disease duration, and age at disease on-
set among the subjects with and without nail involve-
ments. Augustin et al. reported longer disease dura-
tion in patients with (21.9 years) and without (18.1 
years) nail presentations compared with ours (10.29 
and 9/6, years respectively) (10). Velden et al. and 
Brazzelli et al. only reported the duration of disease as 
19 years and 5.23±11.32 years, respectively (4,18). 
We excluded all cases of onychomycosis from 
the study after direct examination, KOH smear, and 
fungal culture. However, onychomycosis may pres-
ent with clinical features resembling nail psoriasis. 
Furthermore, it is estimated that the prevalence of 
onychomycosis is about 4.6% to 30% of patients with 
psoriasis with nail involvement (27,29). the absence 
of nail biopsy procedures could be considered one of 
the limitations of our study.
CONCLUSION
to the best of our knowledge, this is the first study 
showing a correlation between the severity of psori-
atic skin lesions and nail involvement in the north of 
iran. Based on the findings of the present study, many 
patients might present both skin and nail lesions 
which could often be missed during normal physical 
examinations. 
Limitations
this clinical study could be more valuable if we 
had also examined the treatment response of the pa-
tients and nAPSi or nail involvement. 
in addition, we recommend future studies with 
larger sample sizes and performing similar studies in 
other universities around the country with identical 
standards for synchronized comparisons. Further-
more, nail involvement is commonly known to be 
accompanied with articular signs such as sacroiliitis, 
enthesitis (25), or psoriatic arthritis, which should be 
considered in future studies evaluating nAPSi or nail 
involvement and skin severity.
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